How to Image Cardiac Amyloidosis | Zendy

Sharmila Dorbala | Zendy; Sarah Cuddy | Zendy; Rodney H. Falk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

How to Image Cardiac Amyloidosis

Author(s) -

Sharmila Dorbala,

Sarah Cuddy,

Rodney H. Falk

Publication year - 2019

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2019.07.015

Subject(s) - cardiac amyloidosis , transthyretin , amyloidosis , medicine , magnetic resonance imaging , stage (stratigraphy) , disease , amyloid (mycology) , cardiac magnetic resonance , cardiology , restrictive cardiomyopathy , heart failure , radiology , cardiomyopathy , pathology , paleontology , biology

Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with a median survival from diagnosis, if untreated, ranging from <6 months for light chain amyloidosis to 3 to 5 years for transthyretin amyloidosis. Early diagnosis and accurate typing of CA are necessary for optimal management of these patients. Emerging novel disease modifying therapies increase the urgency to diagnose CA at an early stage and identify patients who may benefit from these life-saving therapies. The goal of this review is to provide a practical approach to echocardiography, cardiac magnetic resonance, and radionuclide imaging in patients with known or suspected CA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research